Test Price
2,800 AED✅ Home Collection Available
EPB41L1 Gene-Related Autosomal Dominant Intellectual Disability Type 11 (MRD11) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين EPB41L1 المرتبط بالإعاقة الذهنية الصبغية الجسدية السائدة النوع 11 (MRD11) بتقنية التسلسل الجيني المتطور (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Clinical Precision: 99.9% Diagnostic Sensitivity & Specificity via ISO 9001:2015 Accredited NGS Processing.
ملخص سريري: تحليل دقيق بنسبة حساسية تشخيصية 99.9% عبر مختبر معتمد آيزو، مع جمع عينات منزلي مبرد وخدمة استشارة ما بعد الفحص.
Premium Logistics: ISO-Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM‑11 PM).
Clinical Guidance: Post‑test telephonic result interpretation by a DHA‑licensed genetic counselor.
Insurance & Billing: Direct verification via WhatsApp +971 54 548 8731.
Clinical Overview: EPB41L1 Gene & MRD11
The EPB41L1 gene, encoding protein 4.1B, is strongly linked to autosomal dominant intellectual disability type 11 (MRD11), a neurodevelopmental disorder characterized by developmental delay and cognitive impairment. This NGS-based test sequences the entire coding region of EPB41L1 to detect pathogenic single nucleotide variants, small insertions/deletions, and copy number variations, offering a definitive molecular diagnosis for affected individuals and accurate carrier screening for family members within the UAE. تحليل جين EPB41L1 يكشف الطفرات المسببة للإعاقة الذهنية الوراثية السائدة (النوع 11) بدقة عالية للغاية، مما يمكّن الأطباء من تقديم تشخيص جزيئي موثوق واستشارة وراثية دقيقة.
| Feature | Our EPB41L1 NGS Test | Closest Alternative (CMA/Karyotyping) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – Illumina NovaSeq X Plus | Chromosomal Microarray (CMA) / Conventional Karyotype |
| Resolution | Detects single nucleotide variants, indels & CNVs down to 1bp | Only large structural variants (>50kb–5Mb); misses point mutations |
| Turnaround Time | 3–4 Weeks | 2–4 Weeks (but limited to chromosomal level) |
| Diagnostic Yield for MRD11 | >99% for EPB41L1 gene mutations | Approx. 0% (cannot resolve single-gene defects) |
Physician Insight & Safety Protocol
Clinical Note from Dr. PRABHAKAR REDDY (DHA License: 61713011): “A positive EPB41L1 result confirms the molecular cause of your patient’s intellectual disability and guides prognosis, surveillance, and reproductive counseling. However, a negative result does not eliminate other genetic or environmental aetiologies, and clinical judgment remains paramount. I strongly recommend a structured post‑test genetic counseling session to discuss implications for the family.”
Medication Warning: Do not discontinue any prescribed medication or therapy based solely on genetic test results. Always consult your treating physician before making any changes.
Safety Red Flags – Seek Emergency Care if:
• Sudden onset of severe behavioral changes or aggression.
• New or worsening seizures, loss of consciousness.
• Acute neurological deterioration (loss of developmental milestones).
• Any suspicion of self‑harm or inability to care for oneself.
Exclusion Criteria for Testing:
- Individuals unable to provide informed consent (with legal guardian consent mandatory for minors as per UAE CDS Law 2026).
- Patients declining pre‑test genetic counseling.
- Inadequate sample quality (hemolysis, clotted blood, insufficient volume).
Frequently Asked Questions
Q1: How accurate is the EPB41L1 Genetic Test for intellectual disability?
Our EPB41L1 NGS panel achieves 99.9% analytical sensitivity and 99.9% specificity for detecting all pathogenic variants within the gene’s coding region, validated under ISO 9001:2015 protocols and 2026 DHA standards. يحقق تحليل جين EPB41L1 درجة حساسية تحليلية تصل إلى 99.9% ونوعية مماثلة في كشف جميع الطفرات الممرضة في المنطقة المشفرة للجين، وذلك وفق معايير هيئة الصحة بدبي 2026.
Q2: How long will it take to receive my EPB41L1 test results in the UAE?
Results are typically released within 3 to 4 weeks from the date the sample reaches our Dubai central processing laboratory, with secure electronic reports delivered directly to your requesting physician. تُصدر نتائج تحليل جين EPB41L1 عادةً خلال 3 إلى 4 أسابيع من استلام العينة في مختبرنا المركزي في دبي، مع تقارير إلكترونية آمنة.
Q3: Is genetic counseling mandatory before and after this test?
Yes, pre‑test genetic counseling is mandatory to fully understand the test’s scope, limitations, and potential outcomes, while post‑ counseling ensures appropriate interpretation of results and family planning advice. نعم، الاستشارة الوراثية قبل التحليل إلزامية لفهم نطاقه وحدوده، وتُعد الاستشارة بعد النتيجة ضرورية للتفسير السليم وتوجيه الأسرة.
DHA/MOHAP‑Compliant Code: EPB41L1-NGS‑MRD11 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Laboratory License: 9834453
Data Privacy: Your genomic data is processed in full compliance with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87) and PDPL, encrypted end‑to‑end, and never shared without consent.
Child/Adolescent Policy: Testing of minors strictly follows CDS Law 2026 – written parental/guardian consent and in‑person genetic counseling required.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians